The Los Angeles Times has an article announcing Amgen's move to eliminate 2,200 to 2,600 jobs worldwide — 12 to 14 percent of the company's workforce — in response to declining sales of the anemia drug Aranesp.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.